BSX

Boston Scientific To Participate In Cowen and Company 34th Annual Healthcare Conference

[PR Newswire] – NATICK, Mass., Feb. 26, 2014 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Cowen and Company 34th Annual Healthcare Conference on March 4 in Boston. Dan Brennan, … moreView todays social media effects on BSXView the latest stocks trending across Twitter. Click to view dashboardSee who Boston is hiring next, click here […]

Will Stryker’s Acquisition Spree Strike It Rich?

moreView todays social media effects on BSXView the latest stocks trending across Twitter. Click to view dashboardSee who Boston is hiring next, click here to view […]

Boston Scientific To Participate In The 2014 Citi And RBC Capital Markets Global Healthcare Conferences

[PR Newswire] – NATICK, Mass., Feb. 24, 2014 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in two conferences, the 2014 Citi Global Healthcare Conference and the RBC Capital Markets … moreView todays social media effects on BSXView the latest stocks trending across Twitter. Click to view dashboardSee who Boston is hiring next, click here to view […]

Dystonia Europe and the European Parkinson’s Disease Association (EPDA) Partner With Boston Scientific in Advancing Parkinson’s and Dystonia Care

[PR Newswire] – Dystonia Europe (DE) and the European Parkinson’s Disease Association (EPDA) announced today that they are collaborating with Boston Scientific Corporation (BSX), a global medical technology leader. The aim of these partnerships is to inc moreView todays social media effects on BSXView the latest stocks trending across Twitter. Click to view dashboardSee who Boston is hiring next, click […]

CE Mark for Boston Scientific’s New Stent

moreView todays social media effects on BSXView the latest stocks trending across Twitter. Click to view dashboardSee who Boston is hiring next, click here to view […]

Boston Scientific WallFlexâ„¢ Esophageal Stent Gains CE Mark For The Treatment Of Refractory Benign Esophageal Strictures

[PR Newswire] – NATICK, Mass., Feb. 14, 2014 /PRNewswire/ — Boston Scientific Corporation (BSX) has received CE Mark in Europe for its WallFlexâ„¢ Esophageal Fully Covered Stent to treat refractory benign esophageal strictures. Benign esophageal strictu moreView todays social media effects on BSXView the latest stocks trending across Twitter. Click to view dashboardSee who Boston is hiring next, click here […]

Boston Scientific: Products To Watch In 2014

moreView todays social media effects on BSXView the latest stocks trending across Twitter. Click to view dashboardSee who Boston is hiring next, click here to view […]